Concepedia

Melissa Dumble

MD

Statistics

Publications

24

Citations

1.7K

H-Index

20

Active since

2001

Affiliations

Baylor College of Medicine(Current)

GlaxoSmithKline (United States)

PTC Therapeutics (United States)

The University of Texas MD Anderson Cancer Center

The University of Western Australia

Melissa Dumble is an author at Baylor College of Medicine specializing in molecular oncology, oncology, and medicine.

Publications per year

2001–2025

24

Publications

24

The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging

Melissa Dumble, Lynette M. Moore, Stuart M. Chambers et al. · Blood · 2006 · 239 citations · Full text

, , +14

Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma

Melissa Dumble, Emma Croager, George C. Yeoh et al. · Carcinogenesis · 2002 · 220 citations · Full text

, , +17

A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver

Barbara Akhurst, Emma Croager, Caroline A. Farley-Roche et al. · Hepatology · 2001 · 210 citations · Full text

, , +9

Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor

Melissa Dumble, Ming‐Chih Crouthamel, Shuyun Zhang et al. · PLoS ONE · 2014 · 144 citations · Full text

, , +14

The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells

Yuichiro Nishida, Aya Maeda, M J Kim et al. · Blood Cancer Journal · 2017 · 106 citations · Full text

, , +17

1–5 of 24